Nutra Pharma Corp - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
Nutra Pharma Corp. is a biopharmaceutical company engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. The Company's products are Cobroxin and Nyloxin/Nyloxin Extra Strength. The wholly owned subsidiaries of the Company are ReceptoPharm, Inc. (ReceptoPharm) and Designer Diagnostics, Inc. (Designer Diagnostics).
No news available